EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

ProductUpdated on 4 September 2026

Vero Cell Line

About

Nuvonis provides a GMP Vero cell bank ready for industrial biomanufacturing - the world’s leading continuous mammalian substrate, proven to be non-tumorigenic. 

The Nuvonis Vero cell bank originates from a WHO cell bank established in 1987 at passage level 134.

Cultivated under serum-free and animal component-free conditions, this adherent non-GMO cell line provides a safe, reliable platform globally accepted by authorities.

Attached files

Organisation

Nuvonis Technologies

Company (SME/startup) / 中小企業・スタートアップ

Vienna, Austria

Similar opportunities